Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA)

The optimal strategy for second-line (IIL) treatment in KRAS wt metastatic colorectal cancer (mCRC) is not determined yet.

Source: Digestive and Liver Disease - August 14, 2023 Category: Gastroenterology Authors: P. Di Nardo, D. Basile, A. Siciliano, G. Pelizzari, C. Corvaja, S. Buriolla, E. Ongaro, D. Maria Grazia, S.K. Garattini, L. Foltran, M. Guardascione, M. Casagrande, A. Buonadonna, T. Prantera, G. Aprile, F Puglisi Tags: Meta-Analysis Source Type: research